Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

61
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
61
Drug Discovery: Overview01:26

Drug Discovery: Overview

12.7K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
12.7K
Targets for Drug Action: Overview01:26

Targets for Drug Action: Overview

11.0K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
11.0K
Genomics02:02

Genomics

41.4K
Genomics is the science of genomes: it is the study of all the genetic material of an organism. In humans, the genome consists of information carried in 23 pairs of chromosomes in the nucleus, as well as mitochondrial DNA. In genomics, both coding and non-coding DNA is sequenced and analyzed. Genomics allows a better understanding of all living things, their evolution, and their diversity. It has a myriad of uses: for example, to build phylogenetic trees, to improve productivity and...
41.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Deep learning in multi-omics integration for gastrointestinal cancer biomarker discovery.

Frontiers in oncology·2026
Same author

Interpreting the Black Box: Interpretable Machine Learning and Systems Pharmacology in Small-Molecule Therapeutics.

Pharmaceutics·2026
Same author

Panchromatic Polymer Dot-Bacteria Biohybrid Systems for Photosynthetic CO<sub>2</sub> Reduction into Acetic Acid.

ACS nano·2026
Same author

EGID: A Comprehensive Multi-label Endoscopic Image Dataset for Gastritis Classification.

Scientific data·2026
Same author

Electrochemical Oxidation of Water Through Conducting Polymer for Hydroxyl Radical Generation at Ultra-Low Voltage.

Advanced materials (Deerfield Beach, Fla.)·2026
Same author

Preparation and Photophysical Study of Rhodamine-Perylenebisimide Electron Donor-Acceptor Dyad/Triads Containing Flexible Linkers.

Molecules (Basel, Switzerland)·2026

Related Experiment Video

Updated: Mar 14, 2026

Author Spotlight: Advancing Alzheimer's Research &#8211; Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

2.0K

Deep Learning-Enabled Multi-Omics Integration: A New Frontier in Precise Drug Target Discovery.

Yufei Ren1, Haotian Bai1, Jihan Wang2

  • 1School of Physics and Electronic Information, Yan'an University, Yan'an 716000, China.

Biology
|March 13, 2026
PubMed
Summary

Deep learning (DL) enhances multi-omics integration for precise drug target discovery, overcoming limitations of traditional methods. This approach identifies new disease drivers and prioritizes therapeutic targets for precision medicine.

Keywords:
deep learningdrug target discoverymulti-omics integrationprecision medicine

More Related Videos

Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts
08:51

Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts

Published on: September 20, 2024

2.2K
Using Human Differentially Expressed Gene Lists to Perform Downstream Pathway Enrichment Analysis and Target Prioritization
03:08

Using Human Differentially Expressed Gene Lists to Perform Downstream Pathway Enrichment Analysis and Target Prioritization

Published on: October 3, 2025

1.1K

Related Experiment Videos

Last Updated: Mar 14, 2026

Author Spotlight: Advancing Alzheimer's Research &#8211; Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

2.0K
Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts
08:51

Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts

Published on: September 20, 2024

2.2K
Using Human Differentially Expressed Gene Lists to Perform Downstream Pathway Enrichment Analysis and Target Prioritization
03:08

Using Human Differentially Expressed Gene Lists to Perform Downstream Pathway Enrichment Analysis and Target Prioritization

Published on: October 3, 2025

1.1K

Area of Science:

  • Computational Biology
  • Genomics
  • Pharmacology

Background:

  • Pharmaceutical R&D faces high costs and attrition due to complex diseases.
  • Single-omics methods struggle to capture systemic disease complexity.
  • Deep learning (DL) offers advanced multi-omics integration for drug discovery.

Purpose of the Study:

  • To review advancements in DL-driven multi-omics integration for drug target discovery.
  • To explore DL architectures and integration strategies for multi-omics data.
  • To examine the efficacy of DL in identifying disease drivers and therapeutic targets.

Main Methods:

  • Systematic review of DL applications in multi-omics integration.
  • Delineation of multi-omics data foundations and integration strategies.
  • Exploration of DL architectures (e.g., CNNs, RNNs, GNNs) for omics data processing.

Main Results:

  • DL effectively integrates multi-omics data for identifying novel disease drivers.
  • DL aids in predicting synthetic lethality interactions for targeted therapies.
  • DL enhances the prioritization of potential therapeutic targets.

Conclusions:

  • DL-driven multi-omics integration is a powerful tool for precision drug discovery.
  • Addressing challenges like data sparsity and interpretability is crucial.
  • Emerging AI technologies (Generative AI, LMMs, XAI) offer future opportunities.